IBIO, INC. Non Peo Neo Avg Total Comp Amt
IBIO, INC. (IBIO) reported Non Peo Neo Avg Total Comp Amt of $1.02 million for the 12-month period ending 2026-06-30, per its DEF 14A filed 2026-09-04.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-09-04
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2026-06-30 | $1.02M DEF 14A · filed 2026-09-04 |
| 2025-06-30 | $741.49K DEF 14A · filed 2026-09-04 |
| 2024-06-30 | $761.87K DEF 14A · filed 2026-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |